Read the full article on KETV 7
The Hershey Company says its gum and mint sales are increasing, with demand potentially linked to reports of “Ozempic breath” among users of GLP-1 weight loss drugs. CEO issues remarks during company’s earnings callIn pre-recorded remarks during the company’s earnings call last week, CEO Kirk Tanner said, “We’ve seen strong demand for gum and mints, as the category benefits from functional snacking tailwinds, including GLP-1 adoption.”Retail sales for Hershey’s Ice Breakers gum increased 8% last quarter, according to Tanner. While Tanner did not specify how the increasing use of GLP-1 agonists fueled those sales, some people taking medications like Ozempic, Wegovy, and Mounjaro report experiencing halitosis, or bad breath. What is Ozempic breath?The phenomenon, referred to as “Ozempic breath” in some medical circles, is not an officially listed side effect of the medication.Dental experts have linked the drugs to dry mouth, which they say is likely caused by dehydration and changes to saliva production due to the medication. Other companies seeing a boost in salesHershey is not the only company seeing a boost in sales from GLP-1 users.Swiss chocolatier Lindt reported faster growth in U.S. sales of premium chocolate last year among people using the medication compared to those who weren’t.Similarly, Magnum Ice Cream has also seen increased sales among GLP-1 users.
The Hershey Company says its gum and mint sales are increasing, with demand potentially linked to reports of “Ozempic breath” among users of GLP-1 weight loss drugs.
CEO issues remarks during company’s earnings call
Advertisement
In pre-recorded remarks during the company’s earnings call last week, CEO Kirk Tanner said, “We’ve seen strong demand for gum and mints, as the category benefits from functional snacking tailwinds, including GLP-1 adoption.”
Retail sales for Hershey’s Ice Breakers gum increased 8% last quarter, according to Tanner.
While Tanner did not specify how the increasing use of GLP-1 agonists fueled those sales, some people taking medications like Ozempic, Wegovy, and Mounjaro report experiencing halitosis, or bad breath.
What is Ozempic breath?
The phenomenon, referred to as “Ozempic breath” in some medical circles, is not an officially listed side effect of the medication.
Dental experts have linked the drugs to dry mouth, which they say is likely caused by dehydration and changes to saliva production due to the medication.
Other companies seeing a boost in sales
Hershey is not the only company seeing a boost in sales from GLP-1 users.
Swiss chocolatier Lindt reported faster growth in U.S. sales of premium chocolate last year among people using the medication compared to those who weren’t.
Similarly, Magnum Ice Cream has also seen increased sales among GLP-1 users.
